Abstract

IntroductionT helper (Th)-17 cells are increased in systemic sclerosis (SSc). We therefore assessed whether Th17 cells could modulate the inflammatory and fibrotic responses in dermal fibroblasts from healthy donors (HD) and SSc individuals.MethodsFibroblasts were obtained from 14 SSc and 8 HD skin biopsies. Th17 clones were generated from healthy peripheral blood upon enrichment of CC chemokine receptor (CCR)-4/CCR6/CD161 expressing cells. Their cytokine production was assessed by flow cytometry and multiplex beads immunoassay. Fibroblast production of monocyte chemoattractant protein (MCP)-1, interleukin (IL)-8, matrix metalloproteinase (MMP)-1, tissue inhibitor of metalloproteinase (TIMP)-1, MMP-2 and type-I collagen was quantified by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA), and changes in their transcription levels assessed by real-time PCR. Intracellular signals were dissected by western blot and the use of pharmacological inhibitors. IL-17A, tumor necrosis factor (TNF) and interferon-gamma (IFN-γ) blocking reagents were used to assess the specificity of the observed effects.ResultsIL-17A increased MCP-1, IL-8 and MMP-1 production in a dose-dependent manner while having no effect on type I collagen in HD and SSc fibroblasts both at protein and mRNA levels. Nuclear factor-kappa B (NF-κB) and p38 were preferentially involved in the induction of MCP-1 and IL-8, while MMP-1 was most dependent on c-Jun N-terminal kinase (JNK). Supernatants of activated Th17 clones largely enhanced MCP-1, IL-8 and MMP-1 while strongly inhibiting collagen production. Of note, the production of MCP-1 and IL-8 was higher, while collagen inhibition was lower in SSc compared to HD fibroblasts. The Th17 clone supernatant effects were mostly dependent on additive/synergistic activities between IL-17A, TNF and in part IFN-γ. Importantly, the inhibition of type I collagen production induced by the Th17 clone supernatants was completely abrogated by blockade of IL-17A, TNF and IFN-γ mostly in SSc fibroblasts, revealing an intrinsic resistance to inhibitory signals in SSc.ConclusionsOur findings demonstrate that in vitro Th17 cells elicit pro-inflammatory responses while restraining collagen production. Thus, the increased Th17 cell number observed in SSc may impact on the inflammatory component of the disease simultaneously potentially providing a protective role against fibrosis.

Highlights

  • T helper (Th)-17 cells are increased in systemic sclerosis (SSc)

  • IL-17A enhances monocytes chemoattractant protein (MCP)-1, IL-8 and matrix metalloproteinases (MMP)-1 but not type I collagen production in healthy donors (HD) and SSc dermal fibroblasts Several lines of evidence indicate that Th17 cells and their hallmark cytokine IL-17A are increased in SSc [15,16,17,18,19,20,21]

  • We assessed whether IL-17A can affect the capacity of dermal fibroblasts from SSc and HD to produce inflammatory cytokines and extracellular matrix (ECM) components known to be upregulated in SSc

Read more

Summary

Introduction

T helper (Th)-17 cells are increased in systemic sclerosis (SSc). We assessed whether Th17 cells could modulate the inflammatory and fibrotic responses in dermal fibroblasts from healthy donors (HD) and SSc individuals. Systemic sclerosis (SSc) is an autoimmune disorder of unknown origin characterized by fibro-proliferative microangiopathy and progressive fibrosis of the skin and internal organs [1,2]. MCP-1 and IL-8 are increased in the skin and serum of SSc patients [4,5] and appear to be critical in mediating bleomycin-induced lung and dermal fibrosis [6,7]. T cells infiltrate SSc skin early and fibroblasts with high synthetic activity localize in close proximity to the inflammatory infiltrate (reviewed in [8]). We and others have reported that SSc individuals have increased Th17 cell counts in their peripheral blood and skin [15,16,17,18,19,20,21]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.